Abstract
Purpose. The effects of omeprazole on indinavir when administered alone or in combination with ritonavir were evaluated.
Methods. Fourteen men and women age 18-55 years not infected with human immunodeficiency virus who met study qualifications were randomized.to receive placebo, 20 mg of omeprazole, or 40 mg of omeprazole daily. After seven days, the single-dose pharmacokinetic profile of an 800-mg dose of indinavir alone or in combination with 200 mg of ritonavir was evaluated. Study participants received each of four study regimens in one of four randomly assigned orders. Blood samples were collected, and plasma indinavir and ritonavir concentrations were analyzed using high-performance liquid chromatography.
Results. The coadministration of 20 or 40 mg of omeprazole with indinavir significantly reduced the mean indinavir area under the concentration-versus-time curve (AUC) from 30.0 mg center dot hr/L (95% confidence interval [Cl], 21.9-41.1 mg center dot hr/L) to 19.7 mg center dot hr/L (95% Cl, 14.6-26.8 mg hr/L) or 16.0 mg center dot hr/L (95% Cl, 11.8-21.7 mg center dot hr/L), respectively (p < 0.002). The addition of 200 mg of ritonavir to 800 mg of indinavir in combination with 40 mg of omeprazole significantly increased the mean indinavir AUC from 30.0 mg center dot hr/L (95% Cl, 21.9-41.1 mg center dot hr/L) to 46.6 mg hr/L (95% Cl, 34.0-63.8 mg center dot hr/L), but it did not significantly affect mean omeprazole concentrations (p <= 0.02).
Conclusion. The AUC of indinavir was substantially decreased in healthy volunteers who received omeprazole 20 or 40 mg daily for seven days before the administration of a single 800-mg dose of indinavir. Concomitant administration of ritonavir 200 mg with indinavir in participants receiving omeprazole led to a significant increase in the AUC of indinavir.